Assay device, composition, and method of optimizing assay sensitivity

• US 20050101032A1
• Filed: 08/27/2004
• Published: 05/12/2005
• Est. Priority Date: 02/10/1997
• Status: Abandoned Application

• Current Assignee: Bayer Healthcare LLC (Bayer AG)
• Original Assignee: Metrika, Inc. (Bayer AG)
• Inventors: Blatt, Joel M., Mangan, Wilma M.
• Application Number:
  US10/927,637
• Publication Number:
  US 20050101032A1
• Time in Patent Office: Days
• US Class Current: 436/518
• CPC Class Codes: G01N 33/54373 involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
• CPC Class Codes: G01N 33/551 the carrier being inorganic

Abstract

The present invention provides an assay composition for producing a physically detectable change upon contact with a sample which correlates with the amount of selected analyte in the sample. The composition includes a support matrix pervious to optical radiation and a chemical reagent yielding a physically detectable change which correlates with the amount of selected analyte in the sample. The support matrix has at least one detection zone for detecting the physical change with a cross-sectional area and depth profile. The composition includes an opacifier present in an amount sufficient to increase the resolution of the physically detectable change. The opacifier is distributed uniformly across the cross-sectional area of the detection zone and is distributed through at least a portion of the depth profile of the support matrix within the detection zone. The chemical reagent is substantially immobilized relative to the opacifier when detecting the physical change. The assay composition can be supported on a transport matrix and used in an assay device. The present invention determines the level of a selected analyte in a sample by optimizing a physically detectable change in an assay composition which correlates with the amount of selected analyte when contacted with the sample. The present invention optimizes the assay results of a selected analyte in a sample-exposed assay composition by increasing the reflection of optical radiation detecting a physical change of the sample-exposed assay composition to be within the range of optimal assay resolution.

Claims

1. An assay composition for producing a physically detectable change upon contact with a sample which correlates with the amount of selected analyte in the sample, the composition comprising:

a support matrix pervious to optical radiation;

a chemical reagent yielding a physically detectable change which correlates with the amount of selected analyte in the sample, the support matrix having at least one detection zone for detecting the physical change, the detection zone having a cross-sectional area and a depth profile extending into the support matrix;

an opacifier present in an amount sufficient to increase the resolution of the physically detectable change, the opacifier being distributed uniformly across the cross-sectional area of the detection zone and being distributed through at least a portion of the depth profile of the support matrix within the detection zone, the chemical reagent being substantially immobilized relative to the opacifier when detecting the physical change.

2. The composition of claim 1 wherein the opacifier is present in an amount sufficient to increase the reflectance of optical radiation into a range providing the least error for detecting the physical change.

3. The composition of claim 1 wherein the opacifier is present in an amount sufficient to increase the reflectance of optical radiation into a range providing the greatest contrast for detecting the physical change with the smallest change in the selected analyte concentration.

4. The composition of claim 1 wherein the opacifier is present in an amount sufficient to increase the reflectance of optical radiation into a range of about 20% to about 80% reflectance percentage which minimizes the error in K/S for the analytical range of clinical interest in the selected analyte.

5. The composition of claim 1 wherein the physically detectable change is a variation of color.

6. The composition of claim 1 wherein the opacifier is distributed uniformly through the depth profile of the support matrix within the detection zone.

7. The composition of claim 1 wherein the opacifier is present in an amount of about 5% to about 15% by weight/volume of the opacifier.

8. The composition of claim 1 wherein the opacifier is present in an amount of about 10% to about 15% by weight/volume of the opacifier.

9. The composition of claim 1 wherein the opacifier is selected from the group consisting of titanium dioxide, barium sulfate, zinc oxide, silica, lead oxide, diatomaceous earth materials, colloidal materials, and microcrystalline synthetic polymers.

10. The composition of claim 1 wherein the opacifier is rutile titanium dioxide.

11. The composition of claim 1 wherein the opacifier having a surface area in the amount greater than about 10 m²/g.

12. The composition of claim 1 wherein the opacifier is in the shape of particles, each particle having a diameter in the range of about 0.2 μ

m to about 0.4 μ

m.

13. The composition of claim 1 wherein the opacifier is in the shape of particles, each particle having a diameter of about 0.3 μ

m.

14. A transport matrix producing a physically detectable change in a detection zone which correlates with the amount of selected analyte in a sample, the matrix comprising:

a detection zone having a chemical reagent yielding a physically detectable change which correlates with the amount of selected analyte in the sample, the detection zone having a cross-sectional area and a depth profile extending into the matrix;

an opacifier present in an amount sufficient to increase the resolution of detecting the physical change, the opacifier being distributed uniformly across the cross-sectional area of the detection zone and being distributed through at least a portion of the depth profile of the matrix within the detection zone, the opacifier being substantially immobilized relative to the chemical reagent in the detection zone when detecting the physical change.

15. The transport matrix of claim 14 wherein the opacifier is present in an amount sufficient to increase the reflectance of optical radiation into a range providing the least error for detecting the physical change.

16. The transport matrix of claim 14 wherein the opacifier is present in an amount sufficient to increase the reflectance of optical radiation into a range providing the greatest contrast for detecting the physical change with the smallest change in the selected analyte concentration.

17. The transport matrix of claim 14 wherein the opacifier is present in an amount sufficient to increase the reflectance of optical radiation into a range of about 20% to about 80% reflectance percentage which minimizes the error in K/S for the analytical range of clinical interest in the selected analyte.

18. The transport matrix of claim 14 wherein the physically detectable change is a variation of color.

19. The transport matrix of claim 14 wherein the opacifier is distributed uniformly through the depth profile of the matrix within the detection zone.

20. The transport matrix of claim 14 wherein the opacifier is present in an amount of about 5% to about 15% by weight/volume of the opacifier.

21. The transport matrix of claim 14 wherein the opacifier is present in an amount of about 10% to about 15% by weight/volume of the opacifier.

22. The transport matrix of claim 14 wherein the opacifier is selected from the group consisting of titanium dioxide, barium sulfate, zinc oxide, silica, lead oxide, diatomaceous earth materials, colloidal materials, and microcrystalline synthetic polymers.

23. The transport matrix of claim 14 wherein the opacifier is rutile titanium dioxide.

24. The transport matrix of claim 14 wherein the opacifier having a surface area in the amount greater than of about 10 m²/g.

25. The transport matrix of claim 14 wherein the opacifier is in the shape of particle having a size in the range of about 0.2 μ

m to about 0.4 μ

m.

26. The transport matrix of claim 14 wherein the opacifier is in the shape of particle having a size of about 0.3 μ

m.

27. A diagnostic device for determining the presence of a selected analyte in a sample, the device comprising:

a housing having an exterior surface and sealing an interior area;

a receptor configured to receive the sample containing an analyte selected for determining its presence, the receptor being located on the exterior surface of the housing;

at least one transport matrix for reacting the sample with a chemical reagent to yield a physically detectable change in a detection zone which correlates with the amount of selected analyte in the sample, the detection zone having a cross-sectional area and a depth profile extending into the matrix, an opacifier present in an amount sufficient to increase the resolution of detecting the physical change, the opacifier being distributed uniformly across the cross-sectional area of the detection zone and distributed through at least a portion of the depth profile of the matrix within the detection zone, the opacifier being substantially immobilized relative to the chemical reagent in the detection zone when detecting the physical change.

28. The device in claim 27 wherein the transport matrix produces a physically detectable change in a plurality of detection zones which correlates with the amount of selected analyte in a sample, the matrix including at least a first and a second detection zone, at least one of the detection zones having the chemical reagent yielding a physically detectable change which correlates with the amount of selected analyte in the sample, the opacifier being immobilized in the detection zone relative to the chemical reagent.

29. The device in claim 27 wherein the first and second detection zone contain the reagent and the opacifier.

30. The device in claim 27 wherein the selected analyte is creatinine.

31. The device of claim 27 wherein the opacifier is present in an amount sufficient to increase the reflectance of optical radiation into a range providing the least error for detecting the physical change.

32. The device of claim 27 wherein the opacifier is present in an amount sufficient to increase the reflectance of optical radiation into a range providing the greatest contrast for detecting the physical change with the smallest change in the selected analyte concentration.

33. The device of claim 27 wherein the opacifier is present in an amount sufficient to increase the reflectance of optical radiation into a range of about 20% to about 80% reflectance percentage which minimizes the error in K/S for the analytical range of clinical interest in the selected analyte.

34. The device of claim 27 wherein the opacifier is distributed uniformly through the depth profile of the matrix within the detection zone.

35. The device of claim 27 wherein the opacifier is selected from the group consisting of titanium dioxide, barium sulfate, zinc oxide, silica, lead oxide, diatomaceous earth materials, colloidal materials, and microcrystalline synthetic polymers.

36. A method for determining the level of a selected analyte in a sample, the method comprising the step of:

optimizing a physically detectable change in an assay composition which correlates with the amount of selected analyte when contacted with the sample.

37. The method of claim 36 wherein the optimizing step includes supporting the assay composition in a detection zone on a transport matrix.

38. The method of claim 36 wherein the optimizing step includes supporting a reagent and an opacifier in the detection zone and increasing the reflectance of the physically detectable change with the opacifier.

39. The method of claim 36 wherein the supporting step includes distributing the opacifier uniformly across the cross-sectional area of the detection zone and distributing the opacifier at least partially across the depth profile of the matrix in the detection zone.

40. The method of claim 36 wherein the supporting step includes distributing the opacifier uniformly through the depth profile of the matrix in the detection zone.

41. The method of claim 40 wherein the distributing step includes impregnating the opacifier by contacting the matrix with a solution containing the opacifier.

42. The method of claim 40 wherein the distributing step includes impregnating the opacifier by spraying the matrix with a solution containing the opacifier.

43. A method of optimizing the assay results of a selected analyte in a sample-exposed assay composition, the method comprises:

increasing the reflection of optical radiation detecting a physical change of the sample-exposed assay composition to be within the range of optimal assay resolution.

44. The method of claim 43 wherein the increasing step includes:

scattering the optical radiation directed within the sample-exposed assay composition prior to detecting the physical change of the sample-exposed assay composition.

45. The method of claim 43 wherein, prior to the step of increasing the reflectance, the method includes decreasing the baseline reflectance signal for the assay composition.

46. The method of claim 43 wherein, prior to the step of increasing the reflectance, the method includes optimizing the baseline reflectance signal for the assay composition to produce at least the minimal level of reflectance decrease for the lowest analyte concentration expected to assay in the sample.

47. The method of claim 46 wherein the step of optimizing the baseline reflectance signal includes increasing the porosity of the assay composition.

48. The method of claim 46 wherein the step of optimizing the baseline reflectance signal includes increasing the intensity of the detectable color change for a given concentration of analyte expected to assay in the sample.

49. The method of claim 43 wherein, prior to the step of increasing reflectance, the method includes:

determining the baseline reflectance signal of the assay composition;

impregnating an opacifier in the assay composition in an amount sufficient to increase the reflectance of optical radiation detecting a physical change of the sample exposed assay composition to be within the range of optimal assay resolution.

50. The method of claim 43 wherein the method includes supporting the assay composition in a detection zone on a transport matrix.

51. The method of claim 43 wherein, prior to the step of increasing reflectance, the method includes:

adjusting the signal to noise ratio of a reflectometer over a predetermined range of reflectance;

impregnating an opacifier in the assay composition in an amount sufficient to increase the reflectance of optical radiation detecting a physical change of the sample exposed assay composition to be within the range of optimal assay resolution; and

subsequent to the step of increasing the reflectance, detecting the physical change of the assay composition with a reflectometer.